Framework agreements for the purchase of vaccines for the Danish vaccination programme are offered, divided into two sub-agreements, cf. section II.2.4 below.

At the time of submission of the offer, the offered vaccine must have a marketing authorisation valid for Denmark, cf. section 7 of the Danish Medicines Act. Further requirements for the vaccine are set out in the tender documents.

A framework agreement is offered with 1 supplier for the purchase of a 5 component vaccine that must contain the components diphtheria, tetanus, whooping cough, polio and hib and in case of vaccination the vaccine must be able to be given as one injection. The vaccine must not contain either fewer or more vaccine components than the 5 components described above.

The vaccine must be used as a primary vaccine for infants and must be included in the Danish Childhood Vaccination Programme, cf. Appendix 1.

It is estimated that the need for the purchase of vaccines under the contract is basically approx. 180,000 – 250,000 doses annually, based on the estimated consumption and the current Danish vaccination programme.

The purpose of the framework agreement is to ensure that the SSI can make the necessary purchases of vaccines for the Danish vaccination programme in accordance with the expected need for such vaccines during the framework agreement's term of up to 4 years. The purchase under the agreement depends on the decisions made for the public vaccination programme and on the vaccination coverage in the birth cohorts concerned. In view of this and the fact that the total need for vaccines may vary significantly, the SSI may purchase up to 1,250,000 doses of vaccines in accordance with the framework agreement during its term, cf. Appendix 2 to the framework contract.

A framework agreement is offered with 1 supplier for the purchase of a 4-component vaccine that must contain the components diphtheria, tetanus, whooping cough and polio and in case of vaccination, the vaccine must be able to be given as one injection. The vaccine must not contain either fewer or more vaccine components than the 4 components described above.

The vaccine must be used as a 5-year booster vaccine and must be able to be included in the Danish Childhood Vaccination Programme, cf. Appendix 1.

It is estimated that the need for the purchase of vaccines under the contract is basically approx. 55,000 – 65,000 doses annually, based on the estimated consumption and the current Danish vaccination programme.

The purpose of the framework agreement is to ensure that the SSI can make the necessary purchases of vaccines for the Danish vaccination programme in accordance with the expected need for such vaccines during the framework agreement's term of up to 4 years. The purchase under the agreement depends on the decisions made for the public vaccination programme and on the vaccination coverage in the birth cohorts concerned. In view of this and the fact that the total need for vaccines may vary significantly, the SSI may purchase up to 350,000 doses of vaccines in accordance with the framework agreement during its term, cf. Appendix 2 to the framework contract.